Japan Science and Technology Agency (JST) to Automate Indexing of 90 Journals in SciVerse Scopus

AMSTERDAM, February 16, 2011 - Elsevier and the Japan Science and
Technology Agency (JST) have reached a new agreement for the automated
delivery of the metadata of 90 J-STAGE journals in SciVerse Scopus,
reflecting the mutual commitment of Elsevier and JST to the global
dissemination of scientific research.

"SciVerse Scopus continues to improve indexing peer-reviewed literature,
building a global, reliable database. This agreement between Elsevier and JST
sets a good example of worldwide recognition of Japanese academic journals,"
said Ms. Mikiko Tanifuji, General Manager of the Scientific Information
Office and Publishing Director of Science and Technology of Advanced
Materials at the National Institute for Materials Science in Japan. Ms.
Tanifuji sits on the Content Selection Advisory Board for SciVerse Scopus.

JST has been utilizing Scopus custom data to analyze scientific research
in Japan at a national level. The indexing of J-STAGE journals in SciVerse
Scopus builds upon Elsevier's existing cooperation with JST and will extend
further exposure to the research published within those titles to the global
academic community. Metadata from J-STAGE will continuously and automatically
be indexed within SciVerse Scopus with immediate effect.

"I believe that SciVerse Scopus can make articles on J-STAGE much more
visible globally," said Yoshiyuki Miyagawa, Manager, Group of Electronic
Journals within the Department of Databases for Information and Knowledge
Infrastructure at JST. He added that the uptake of data from J-STAGE to
SciVerse Scopus will be made much easier under this new agreement: "It will
be a good start for the future relationship between Elsevier and JST as
well."

J-STAGE was developed in 1999 to encourage Japanese research societies to
publish their academic journals electronically on a central platform. As the
world's largest abstract and citation database of peer-reviewed literature,
SciVerse Scopus magnifies the mission of J-STAGE to disseminate published
research within those journals at a targeted, global level.

About Japan Science and Technology Agency (JST)

Japan Science and Technology Agency (JST)
(www.jst.go.jp/EN/index.html) aims to establish Japan as a nation
built on the creativity of science and technology and innovation, as a
core organization for implementing Japan's science and technology policy in
line with the objectives of the Science and Technology Basic Plan. JST's
mission is to promote science and technology in Japan by conducting a broad
range of activities, including the following:

* Promotion of consistent research and development from basic research to
commercialization with particular emphasis on the creation of new
technological seeds

* Upgrading the infrastructure for the promotion of science and
technology, including dissemination of scientific and technological
information

About SciVerse Scopus

Covering the world's research literature, SciVerse Scopus
(www.info.sciverse.com/scopus/) is the largest
abstract and citation database of peer-reviewed literature and quality Web
sources with smart tools to track analyze and visualize research. SciVerse
Scopus was designed and developed with over 500 users and librarians
internationally. Its unique database contains abstracts and references from
over 18,000 peer-reviewed journals from more than 5,000 publishers worldwide,
ensuring broad interdisciplinary coverage. In addition, SciVerse Scopus not
only offers users citation information about the articles covered, but also
directly integrates Web and patent searches. Direct links to full-text
articles, library resources and other applications like reference management
software, make SciVerse Scopus quicker, easier and more comprehensive to use
than any other literature research tool.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical
and medical information products and services. The company works in
partnership with the global science and health communities to publish more
than 2,000 journals, including The Lancet (www.thelancet.com/) and
Cell (www.cell.com/), and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
SciVerse ScienceDirect (www.sciencedirect.com/), SciVerse Scopus
(www.scopus.com/), Reaxys (www.reaxys.com/), MD Consult
(www.mdconsult.com/) and Nursing Consult (
www.nursingconsult.com/), which enhance the productivity of science
and health professionals, and the SciVal suite (www.scival.com/) and
MEDai's Pinpoint Review (www.medai.com/), which help research and
health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier
(www.elsevier.com/), employs 7,000 people worldwide. The company is
part of Reed Elsevier Group PLC (www.reedelsevier.com/), a
world-leading publisher and information provider, which is jointly owned by
Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext
Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock
Exchange).

    Media Contacts
    Sandra Plasse/Jennifer Saunders
    +1-212-752-8338
    splasse@psbpr.com
    jsaunders@psbpr.com

Media Contacts: Sandra Plasse/Jennifer Saunders, +1-212-752-8338, splasse at psbpr.com, jsaunders at psbpr.com